Topiramate
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Topiramate is a broad-spectrum antiepileptic approved for partial-onset and primary generalized tonic-clonic seizures, Lennox-Gastaut syndrome, and migraine prophylaxis. It is also used off-label for weight management (a component of Qsymia), essential tremor, and binge eating disorder.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Topiramate is a broad-spectrum antiepileptic approved for partial-onset and primary generalized tonic-clonic seizures, Lennox-Gastaut syndrome, and migraine prophylaxis. NutriStack rates the supporting evidence as strong. Common adult dosing is 25-50 mg/day initially, titrated to 200-400 mg/day in divided doses for epilepsy; 50-100 mg/day for migraine prophylaxis (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete calcium. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: broad-spectrum seizure control, migraine prevention, weight-neutral to weight-loss promoting. 10 sources indexed (2010–2023), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Exerts anticonvulsant effects through multiple mechanisms: blocks voltage-gated sodium channels, enhances GABA-A receptor activity, antagonizes AMPA/kainate glutamate receptors, and weakly inhibits carbonic anhydrase (isoenzymes II and IV). This multifaceted action reduces neuronal excitability and seizure propagation.
Dosing & protocol.
Rapidly absorbed; bioavailability ~80% and not significantly affected by food. Swallow tablets whole; sprinkle capsules can be opened onto soft food.
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Calcium
MildTopiramate therapy has been associated with changes in bone and mineral metabolism, including lower calcium status markers in some patients.
Full safety detail.
Side effects
- Cognitive dysfunction (word-finding difficulty, impaired concentration)
- Paresthesias (tingling in extremities)
- Weight loss and decreased appetite
- Kidney stones (calcium phosphate)
- Metabolic acidosis
- Fatigue and somnolence
- Acute myopia and secondary angle-closure glaucoma (rare)
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
5- 1Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysisPMIDGiri S, Tronvik E, Linde M et al. · Cephalalgia : an international journal of headache · 2023
Giri S, Tronvik E, Linde M et al.. Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis. Cephalalgia : an international journal of headache. 2023
- 2A Bayesian meta-analysis of topiramate's effectiveness for individuals with alcohol use disorderPMIDFluyau D, Kailasam VK, Pierre CG · Journal of psychopharmacology (Oxford, England) · 2023
Fluyau D, Kailasam VK, Pierre CG. A Bayesian meta-analysis of topiramate's effectiveness for individuals with alcohol use disorder. Journal of psychopharmacology (Oxford, England). 2023
- 3Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic reviewPMIDSteinhoff BJ, Klein P, Klitgaard H et al. · Epilepsy & behavior : E&B · 2021
Steinhoff BJ, Klein P, Klitgaard H et al.. Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review. Epilepsy & behavior : E&B. 2021
- 4Topiramate-associated sexual dysfunction: A systematic reviewPMIDChen LW, Chen MY, Chen KY et al. · Epilepsy & behavior : E&B · 2017
Chen LW, Chen MY, Chen KY et al.. Topiramate-associated sexual dysfunction: A systematic review. Epilepsy & behavior : E&B. 2017
- 5Topiramate in the treatment of alcohol dependence: a meta-analysisPMIDArbaizar B, Diersen-Sotos T, Gómez-Acebo I et al. · Actas espanolas de psiquiatria · 2010
Arbaizar B, Diersen-Sotos T, Gómez-Acebo I et al.. Topiramate in the treatment of alcohol dependence: a meta-analysis. Actas espanolas de psiquiatria. 2010
Reviews & position papers
2- 6Narrative Review of Topiramate: Clinical Uses and Pharmacological ConsiderationsPMIDPearl NZ, Babin CP, Catalano NT et al. · Advances in therapy · 2023
Pearl NZ, Babin CP, Catalano NT et al.. Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations. Advances in therapy. 2023
- 7A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric ObesityPMIDKim A, Nguyen J, Babaei M et al. · Adolescent health, medicine and therapeutics · 2023
Kim A, Nguyen J, Babaei M et al.. A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity. Adolescent health, medicine and therapeutics. 2023
Reference material
3- 8Brandes JL et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965-973.Source linkedPMID
- 9Marson AG et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy. Lancet. 2007;369(9566):1000-1015.Source linkedPMID
- 10Silberstein SD et al. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61(4):490-495.Source linkedPMID
Common questions.
Quick answers about Topiramate, drawn from the data on this page.
What is Topiramate?
Topiramate is a broad-spectrum antiepileptic approved for partial-onset and primary generalized tonic-clonic seizures, Lennox-Gastaut syndrome, and migraine prophylaxis. It is also used off-label for weight management (a component of Qsymia), essential tremor, and binge eating disorder.
What is Topiramate used for?
Commonly cited benefits of Topiramate include: Broad-spectrum seizure control; Migraine prevention; Weight-neutral to weight-loss promoting; Effective as monotherapy or adjunctive therapy. NutriStack rates the overall evidence as strong.
What is a typical dose of Topiramate?
A typical adult dose of Topiramate is 25-50 mg/day initially, titrated to 200-400 mg/day in divided doses for epilepsy; 50-100 mg/day for migraine prophylaxis (as prescribed by your physician). The commonly recommended form is Oral tablets or sprinkle capsules. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Topiramate?
Reported side effects include cognitive dysfunction (word-finding difficulty, impaired concentration), paresthesias (tingling in extremities), weight loss and decreased appetite, kidney stones (calcium phosphate), metabolic acidosis, fatigue and somnolence. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Topiramate?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Topiramate in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.